KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $402.0 million.

  • Bristol Myers Squibb's Change in Acquisitions & Divestments rose 54838.71% to $402.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 7602.5%. This contributed to the annual value of $2.0 billion for FY2025, which is 7602.5% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Change in Acquisitions & Divestments is $402.0 million, which was up 54838.71% from $829.0 million recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Change in Acquisitions & Divestments high stood at $2.1 billion for Q1 2022, and its period low was $41.0 million during Q4 2023.
  • Its 5-year average for Change in Acquisitions & Divestments is $721.8 million, with a median of $635.5 million in 2024.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first tumbled by 9704.76% in 2023, then soared by 110483.87% in 2024.
  • Bristol Myers Squibb's Change in Acquisitions & Divestments (Quarter) stood at $1.2 billion in 2021, then decreased by 3.05% to $1.2 billion in 2022, then plummeted by 96.6% to $41.0 million in 2023, then surged by 51.22% to $62.0 million in 2024, then soared by 548.39% to $402.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $402.0 million in Q4 2025, compared to $829.0 million in Q3 2025 and $524.0 million in Q2 2025.